Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017)
Sintx Technologies' (SINT) quarterly Liabilities from Discontinued Operations came in at 2356000.0 in Q4 2017.
Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017) Analysis & Trends
Sintx Technologies' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 2356000.0 for Q4 2017.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 2356000.0 in Q4 2017; TTM through Dec 2017 was 2356000.0, a N/A change from a year earlier, with the FY2017 full-year figure at 2356000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was little changed at 2356000.0 in Q4 2017 per SINT's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 2356000.0 in Q4 2017 and bottomed at 2356000.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 2.36 Mn |
| Dec 31, 2017 | 2.36 Mn |